EUVIMEDEUVIMED entdecken
Crossref

Sequence variants in the BTD underlying biotinidase deficiency in families of Pakistani origin

Tariq Moatter, Sibtain Ahmed, Hafsa Majid, Lena Jafri, Muhammad Bilal, Najumuddin, Faisal, Aysha Habib Khan

The Journal of Gene Medicine · 2024

DOI: 10.1002/jgm.3597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2024. Verfasst von Tariq Moatter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan. Hauptthemen laut MEDLINE: Biotinidase Deficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biotinidase deficiency ( BTD ) is a rare autosomal recessive metabolic disease, which develops neurological symptoms because of the impaired biotin recycling. Pathogenic mutations on BTD gene cause BTD deficiency. The clinical features and mutation analysis of Pakistani children with BTD deficiency have rarely been described. Herein, for the first time, we report the clinical features, BTD gene mutations and biochemical analysis of seven symptomatic children with BTD deficiency from Pakistan.

Methods

Seven suspected BTD ‐deficient patients who presented abnormal organic acid profiles and clinical features were subjected to Sanger sequencing to identify pathogenic mutations in the BTD gene. The results were analyzed by Mutation Surveyor Software.

Results

All seven patients exhibited common biotinidase deficiency symptoms including hypotonia, developmental delay and seizures. Biochemical analysis shows marked excretion of 3‐hydroxy isovalerate in all cases, followed by 3‐hydroxy propionate and methyl citrate. Sanger sequencing revealed one frame‐shift mutation, c.98_104delinsTCC (p.Cys33Phefs), and two missense mutations, c.1612C>A (p.Arg538Ser) and c.1330G>C (p.Asp444His). All mutations were in the homozygous state and classified as pathogenic in published studies and mutation databases.

Conclusions

This study has validated the BTD variants as the underlying cause of biotinidase deficiency in which molecular testing of BTD is supported by urinary organic acid analysis and clinical diagnosis. Secondly, the strength of the local availability of this test in Pakistan will paved the way for the neonatal screening of biotinidase deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biotinidase DeficiencyInfant, NewbornChildHumansBiotinidasePakistanMutationNeonatal Screening

Stichwörter der Autor:innen

UOAdevelopmental delayseizures BTD mutationssequence variants

Substanzen

Biotinidase

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.
  • Department of Biotechnology, Faculty of Engineering, Science and Technology, Hamdard University, Karachi, Pakistan.
  • Institute of Biochemistry, University of Sindh, Jamshoro, Pakistan.

Zitieren

APA

Moatter, T., Ahmed, S., Majid, H., Jafri, L., Bilal, M., Najumuddin, Faisal, & Khan, A. H. (2024). Sequence variants in the BTD underlying biotinidase deficiency in families of Pakistani origin. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3597

Vancouver

Moatter T, Ahmed S, Majid H, Jafri L, Bilal M, Najumuddin, et al. Sequence variants in the BTD underlying biotinidase deficiency in families of Pakistani origin. The Journal of Gene Medicine. 2024. doi:10.1002/jgm.3597

BibTeX
@article{Moatter2024,
  author = {Moatter, Tariq and Ahmed, Sibtain and Majid, Hafsa and Jafri, Lena and Bilal, Muhammad and Najumuddin and Faisal and Khan, Aysha Habib},
  title = {Sequence variants in the BTD underlying biotinidase deficiency in families of Pakistani origin},
  journal = {The Journal of Gene Medicine},
  year = {2024},
  doi = {10.1002/jgm.3597}
}
Kostenlos starten →